News and Events

Softigel by Procaps: an integrated CDMO in Softgel technologies

softigel-procaps-cphi-1.jpg
 
At Softigel by Procaps, we develop complex products encapsulated in softgel dosage forms and other delivery systems, high potency APIs, differentiated OTC products and nutritional supplements in novel technologies that can help customers get their products to market faster and in an innovative way.
 
Meet the revolution on Softgel technologies: Meet with Softigel ® by Procaps during CPhI North America
 
At CPhI North America, Softigel seeks new OTC consumer healthcare, generic Rx and pharma customers with collaboration opportunities in the US, other highly regulated markets or elsewhere worldwide.  From simple to complex formulations, clinical to commercial manufacturing, and concept to market, we offer the technical expertise you need and the innovation you demand.  Our team of experts will be delighted to sit with you, discuss mutual opportunities and live the Softigel experience.
 
Companies seek our softgel expertise and cGMP manufacturing facilities approved by some of the most demanding regulatory agencies in the world (including FDA, MHRA, TGA, and many others) to help them bring generic softgel products to market, or, they are brand marketers seeking alternate softgel contract manufacturing capacity with special interest in our novel and proprietary technology platforms which offer their brands distinct consumer advantages and life cycle renewal opportunities.
 
We´d love to meet with big pharma and generic companies of the region, also emerging companies and nutraceutical businesses interested in both generics and brand customization to expand their portfolios in innovative dosage forms.
 
About Softigel by Procaps

Softigel® by Procaps is a leading provider of Contract Development and Manufacturing services in softgel advanced technologies for the global pharmaceutical and nutraceutical industries. Through our extensive capabilities and deep expertise in product development and softgel manufacturing, we help different companies bring innovative products to their markets faster, offering their patients and consumers an exceptional experience, high dosage form preference and superior adherence to different therapies. Our advanced delivery platforms, including Softgel and related technologies, plus our proven formulation, manufacturing and regulatory expertise, has enabled us to become an integrated CDMO (or as we call it, an iCDMO), giving customers full-service, turnkey solutions in prescription and OTC drugs and dietary supplements across both development and delivery. Our softgel facilities are approved by FDA, MHRA, TGA and many other regulatory agencies.
 
 
To schedule a meeting with Softigel by Procaps click here: http://www.softigel.com/Mailing/2019/April/CPhI-North-America/index.aspx
April 30 – May 2
Stand # 210
 
Contact:
Softigel@procaps.com.co
www.softigel.com